IMVIONIX

IMVIONIX Acquires U.S. and Canadian Rights to BEOVU® (brolucizumab-dbll), Marking the Company's Official Launch

Acquisition of FDA-Approved Retinal Therapy Signals IMVIONIX's Entry as a Commercial-Stage Ophthalmology Company PEACHTREE CORNERS, Ga., Nov. 10,…